Endocrinology Flashcards
What is diabetes
Metabolic disorder. Hyperglycaemia caused by limited insulin secretion and insulin resistance
Drivers + Diabetes
Warn DVLA, carry glucose meter/strips, check <2hrs before driving and every 2 hours (must be >5mmol)
Typical T1DM features
BMI<25, Young, glucose>11, ketosis
T1DM HbA1C recommendation
<48mmol/mol (6.5%)
Waking glucose(fasting):
4-7mmols/l
Before food - glucose fasting
5-7mmols/l
90 minutes after food (glucose fasting level)
5-9mmols/l
When does insulin need decrease
Intercurrent illness, reduced food intake, impaired renal function, endocrine disorders e.g. Addison’s, coeliac disease, renal/ hepatic impairment
When does insulin need increase
Trauma (accidental/surgery), infection, stress, puberty
What T1DM patients benefit from metformin
> 25 BMI/ >23 in South Asian people to minimise effective insulin dose
Who is continuous insulin offered to
Disabling hypos, high HBA1c>69
What insulin regimen is preferred in T1DM
Basal bolus
T2DM treatment goals
Reduce micro/macrovascular complications by maintaining effective glucose and maintaining HBA1c
Microvascular
Retinopathy, neuropathy, nephropathy
Macrovascular
Ischemic heart disease, peripheral vascular disease, and cerebrovascular disease
Metformin effect
Lowers glucose, increases insulin sensitivity, inhibits gluconeogenesis, inhibits glycogenolysis
Metformin contraindications
Renal impairment (<30), heart failure, liver failure, recent MI
Key metformin side effect
lactic acidosis
What diabetic drugs cause hypos
Sulfonylurea
Meglitinide
Sulfonylureas end in:
Ide = tolbutamide, gilbenclamide
When is long acting sulphonylurea not recommended:
Older patients because of hypos and confusion
When to stop HRT
Severe chest pain, breathlessness, swelling in one calf, severe stomach pain, liver problems , Hypertension, immobile, neurological issues
What activity does Tibolone have
It has oestrogenic, progestogenic and weak androgenic activity
What is vasopresin and desmopressin, and what are they used for
Antidiuretic hormones used to treat pituitary cranial diabetes insipidus
Key differences between vasopressin and desmopressin
Desmopressin is more potent and has longer duration
Sulfonylureas side effects
Weight gain Hypos G6PD deficiency caution Abdominal pain diarrhoea nausea
Sulfonylurea mechanism of action
Increase insulin acting on pancreatic beta cells (augmenting insulin secretion)
Acarbose mechanism of action
Slows digestion to reduce rate of glucose release
Meglitinide mechanism of action
Similar to Sulfonylurea but act on different receptor to stimulate insulin release
Thiazolidinone manifestation - e.g. pioglitazone
Reduces insulin resistance
Cautions/What to look out for with pioglitazone
Heart failure, nausea, toxicity, dark urine, bladder cancer
DPP4 mechanism of action
Inhibit glucagon release, increases insulin secretion
Dpp4 warnings
Pancreatitis
SGLT2 inhibitors mechanism of action
Prevent reabsorption of glucose in kidneys
GLP1 Receptor antagonist mechanism of action
Produce insulin as they are incretin mimetics, (increase insulin secretion, suppressing glucagon secretion,
slow gastric emptying)
When to take Exanatide
1 hour before food and 6 hours apart, never after food
Exanatide warning
Pancreatitis
GLP1 MHRA Warning
Diabetic ketoacidosis when concomitant insulin was rapidly reduced or discontinued
SGLT2i MHRA warnings
SGLT2 inhibitors: monitor ketones in blood during treatment interruption for surgical procedures or acute serious medical illness
Increased risk of lower-limb amputation (mainly toes)
reports of Fournier’s gangrene (necrotising fasciitis of the genitalia or perineum)
Risk of diabetic ketoacidosis with sodium-glucose co-transporter 2 (SGLT2) inhibitors
SGLT2i side effects
Balanoposthitis; constipation; dyslipidaemia; increased risk of infection;
nausea;
thirst;
urinary disorders; urosepsis
What sort of T2DM drug is needed for elderly
Short acting e.g. tolbutamide, gluclazide
When are GLP1 agonists used
After triple therapy
Meglitinide examples
Repaglinide, nateglinide
What antidiabetic is used concomitantly with weight management products
GLP1 agoists
How/when are meglitinides used
In combination with metformin when metformin alone inadequate
When to use short acting insulin
15-30 minutes before food
Soluble insulin peak
1-4 hours
Soluble insulin duration
9hrs